Mobilizing STING Pathway via a Cationic Liposome to Enhance Doxorubicin‐Induced Antitumor Immunity
Advanced Functional Materials · 2025-03 · 35 (10)
DOI: 10.1002/adfm.202416406 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 08.10.2024. Verfasst von Xiaochen Liu und 6 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The efficacy of anthracycline, such as doxorubicin (DOX), is facilitated by cancer cell‐intrinsic type I interferon (IFN‐I) signaling through the induction of immune responses. However, weak and chronic IFN‐I responses from rounds of chemotherapy lead to resistance against DNA damage and acquired resistance to the therapy. An exogenous supply of IFN‐I can improve the chemotherapeutic responses. Herein, a library of cationic liposomes is developed for the optimization of 1, 2‐dioleoyl‐3‐trimethylammonium‐propane (DOTAP) proportions to enhance the lysosome escape and tumor distribution of the stimulator of interferon genes (STING) agonist 2′,3′‐cyclic guanosine monophosphate‐adenosine monophosphate (cGAMP) and DOX. The cationic liposomes with 8% DOTAP release cGAMP into the cytoplasm and increase the concentration of DOX in the tumor by 1.5 times compared with the free drug. Upon accumulation at the tumor site, the optimized liposomes induce immunogenic cell death (ICD) and stimulate the STING signaling, thereby improving the production of endogenous IFN‐I and promoting dendritic cell maturation to mobilize T cell immunity. The tumor growth inhibition rate is 86%, and the median survival time is 1.6‐fold prolonged. This study offers a strategy to enhance the DOX‐induced immune response by activating the STING pathway to supply IFN‐I.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Liu, X., Zhao, Z., Xu, X., Yi, W., Yan, D., Wang, D., & Li, Y. (2025). Mobilizing STING Pathway via a Cationic Liposome to Enhance Doxorubicin‐Induced Antitumor Immunity. Advanced Functional Materials, 35(10). https://doi.org/10.1002/adfm.202416406
Vancouver
Liu X, Zhao Z, Xu X, Yi W, Yan D, Wang D, et al. Mobilizing STING Pathway via a Cationic Liposome to Enhance Doxorubicin‐Induced Antitumor Immunity. Advanced Functional Materials. 2025;35(10). doi:10.1002/adfm.202416406
BibTeX
@article{Liu2025,
author = {Liu, Xiaochen and Zhao, Zhiwen and Xu, Xiaoxuan and Yi, Wenzhe and Yan, Dan and Wang, Dangge and Li, Yaping},
title = {Mobilizing STING Pathway via a Cationic Liposome to Enhance Doxorubicin‐Induced Antitumor Immunity},
journal = {Advanced Functional Materials},
year = {2025},
volume = {35},
number = {10},
doi = {10.1002/adfm.202416406}
}
EUVIMED